Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years)
Medicine Journal (September 2019 - Volume 98 - Issue 38 - p e17251), Wolters Kluwer HealthSeptember 1, 2019
Publications
September 1, 2019
April 19, 2019
January 18, 2019
March 29, 2018
November 7, 2017
October 1, 2009
November 1, 2008
October 1, 2008
September 1, 2008
Research
We are proud to be on the cusp of cutting-edge research.
September 1, 2019
Case report of long-term survival with metastatic triple-negative breast carcinoma: Treatment possibilities for metastatic disease
Medicine Journal (April 2019 - Volume 98 - Issue 16 - p e15302), Wolters Kluwer HealthApril 19, 2019
Sequential gemcitabine (G), oxaliplatin (O), and irinotecan (I) based weekly metronomic chemotherapy (MC) regimens for the treatment of metastatic pancreatic cancer (mPC): A community cancer clinic ex
ASCO Meeting LibraryJanuary 18, 2019
Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
American Association for Cancer Research - Clinical Cancer ResearchMarch 29, 2018
Eleven-Year Survival with Unresectable Metastatic Pancreatic Carcinoma: A Roadmap to Long-term Survival for Metastatic Disease
Journal of the Pancreas, Volume 18, Issue 6November 7, 2017
Five-Year Survival of Metastatic Pancreatic Carcinoma: A Study of Courage and Hope
National Center for Biotechnology Information, U.S. National Library of MedicineOctober 1, 2009
Long-Term Survival in Metastatic Pancreatic Adenocarcinoma and Cholangiocarcinoma Can Be Achieved With “Metronomic Dosing” of Paclitaxel/Oxaliplatin/Leucovorin/5-Fluorouracil (POLF) and Possibly Other
National Center for Biotechnology Information, U.S. National Library of Medicine, NIHNovember 1, 2008
Exciting Results With Weekly "Metronomic Dosing" of Paclitaxel, Oxaliplatin, Leucovorin, and 5-Fluorouracil (POLF) in the Treatment of Metastatic Pancreatic Cancer
National Center for Biotechnology Information, U.S. National Library of Medicine, NIHOctober 1, 2008
Updated Data Confirm Excellent Activity of Weekly “Metronomic Dosing” of Paclitaxel, Oxaliplatin, Leucovorin, and 5-Fluorouracil (POLF) in Metastatic Pancreatic Adenocarcinoma
National Center for Biotechnology Information, U.S. National Library of Medicine, NIHSeptember 1, 2008